{ "models": [ "MetacellFormer", "Geneformer-V2", "scPRINT", "scGPT", "Geneformer-V1", "CellFM" ], "comparisons": [ "GSE303411_PC9_persister", "GSE196018", "GSE282074_PC9_gefitinib", "GSE282074_PC9_osimertinib" ], "training_source": "scDrugMap Data11 / GSE149214, PC9 parental versus 11-day erlotinib DTEP; 2,393 cells", "training_label": "DTEP positive", "external_label": "cells surviving drug treatment positive", "classifier": "two hidden ReLU layers of 512 units, two-output head; BCEWithLogitsLoss; AdamW lr=0.0001, weight_decay=0.01; training/test batches 128/256; 10 epochs; final epoch", "seeds": [ 1, 2, 3 ], "score": "Average precision using raw class-1 logit", "preprocessing": "Native frozen embeddings; no PCA or external-study tuning", "summary": "Arithmetic mean across three classifier seeds; no pooled-study mean or biological significance test", "shared_controls": "GSE282074 gefitinib and osimertinib comparisons share DMSO controls", "qc": "mapped total counts >=1000; detected genes >=200; mitochondrial fraction <=0.20; at least 20 cells per class", "source_metadata": "Frozen local analysis contracts; source datasets remain subject to their terms." }